About Medical Consulting

Dr. KaT Zarychta is a highly accomplished healthcare leader and business development expert with over 20 years of global experience driving innovation and commercial success in the medical device and biotechnology sectors.  Her expertise spans strategy, market access, due diligence, digital health, and entrepreneurship.

Dr. Zarychta holds a PhD in Laser Physics from Sorbonne Paris North University, two Master's degrees specializing in Physics and Biomedical Engineering, and has completed executive programs at Harvard Business School and Harvard Medical School in areas such as finance, negotiation, disruptive strategy, entrepreneurship, and digital health.

As an Expert Advisor for the European Commission and other organizations (including the Research and Innovation Foundation (RIF) in Cyprus and Innovation Fund Montenegro), Dr. Zarychta has evaluated over 600 innovative projects, spanning diagnostics, therapies, medical devices, digital health, biotechnology, and food technology. She has contributed significantly to programs like Horizon Europe, EIC Pathfinder, and Transition Challenges, focusing on removing barriers to patient access to medical technologies.  She also serves as an Expert Evaluator and Mentor for WomenTechEU.

Her commercial achievements include securing a €35 million loan from the European Investment Bank for the European expansion and commercialization of a nanotechnology cancer therapy at MagForce, where she served as VP of Oncology Market Development for Europe. She also spearheaded the successful European market entry and commercialization of a digital health solution at HistoIndex, significantly increasing sales revenue.  Furthermore, she has founded her own consulting company, advising VCs, angel investors, and startups on due diligence, innovation assessment, and business strategy.  She continues to mentor pre-seed startups at the Founder Institute.

Dr. Zarychta’s technical background includes expertise in areas such as optics, laser physics, near-infrared spectroscopy, and biomedical imaging. This strong foundation, combined with her business acumen and global leadership experience across Europe, Asia-Pacific, and the Middle East, enables her to effectively navigate complex challenges and drive impactful results in the healthcare industry.  She is fluent in Polish, French, English, German, and Spanish, with advanced proficiency in Russian and an intermediate level in Italian and Ukrainian.

Dr. Beata Prycel is a seasoned multitalented Medical Doctor, with a wide scope of expertise in Market Access, Strategy, Marketing and Business.. She graduated at Medical University of Gdansk and received an EMBA, UT Warsaw. (with London Business School, HEC Paris & Norwegian School of Economics).  She was trained in Effective Thought Leader Program, Lisbon; Value Based Selling, London ; Advance Strategy, MSI Consultancy, London; as well as Marketing Strategy & Market Building, Delivering Great Brands, Marketing Excellence Program, Market Research & Insights, The Chartered Institute of Marketing; Henley Institute of London.

She has a strong expertise in the innovative Pharma market and clinical trials in variety of therapeutical areas like: immunology, oncology, hematology, allergology, CNS, dermatology, diabetology, pulmonology and orphan drugs, serving for the Big Pharma Companies – GSK, Eli Lilly, Novartis, AMGEN, Alexion & Sanofi and CROs. The list of her achievements is including: record level on medical and business strategy & development; Strategic management approach for Pharma products portfolio & pipeline; Building clinical networking, supervision and portfolio assesment; Establishing effective collaboration with KOL’s, NGO’s  & PAG’s. Development of the digital opinion leaders management; Building successful x-functional cooperation within the big Pharma environment. Coordination of clinical trials for CEE Region; Building successful strategy for orphan diseases in CEE & Baltics countries; Development of the pipeline strategy for South-East European markets : Belarus, Ukraine, Lithuania, Latvia; Consolidation of the pipeline and portfolio of local Pharma producers; Entering on the EU market with the biggest Pharma products; Creating and successfully implementing rebranding campaign awarded on European level; Medical supervision of coordinator of international clinical projects in EU & Asia; Creating of the multi-channel strategy  for pharma business. Developing and managing the price strategy for the big value & commodity products; Improving the effectiveness of new IT technologies in Pharma Market - developing first in Poland  e-videocommunication platform for diabetes medical community and  iPAD usage project for the SR’s. She also created the market access co-promotion strategies for new products; Implemented successful stakeholders management as a member of Country Commercialization Committee process of Pharma Companies Alliance.